Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

A New Technique Using 4DCT Scans to Create Custom Cardiac Blocks for Left Sided Breast Cancer Treatments.

DuPre PJ, Fitzherbert CM, Hand CM, Solin LJ.

Pract Radiat Oncol. 2019 Jun 18. pii: S1879-8500(19)30164-X. doi: 10.1016/j.prro.2019.06.002. [Epub ahead of print]

PMID:
31226442
2.

Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions.

Solin LJ.

Curr Oncol Rep. 2019 Mar 5;21(4):33. doi: 10.1007/s11912-019-0777-3. Review.

PMID:
30834994
3.

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.

Lehman CD, Gatsonis C, Romanoff J, Khan SA, Carlos R, Solin LJ, Badve S, McCaskill-Stevens W, Corsetti RL, Rahbar H, Spell DW, Blankstein KB, Han LK, Sabol JL, Bumberry JR, Gareen I, Snyder BS, Wagner LI, Miller KD, Sparano JA, Comstock C.

JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6269. [Epub ahead of print]

PMID:
30653209
4.

Contemporary Guidelines in Whole-Breast Irradiation: An Alternative Perspective.

Recht A, McArthur H, Solin LJ, Tendulkar R, Whitley A, Giuliano A.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):567-573. doi: 10.1016/j.ijrobp.2018.10.014. Epub 2018 Oct 23. Review.

PMID:
30366007
5.

Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer.

Kushner CJ, Hwang WT, Wang S, Solin LJ, Vapiwala N.

Breast Cancer Res Treat. 2018 Jul;170(1):45-53. doi: 10.1007/s10549-018-4729-7. Epub 2018 Feb 27.

PMID:
29488126
6.

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.

Rakovitch E, Gray R, Baehner FL, Sutradhar R, Crager M, Gu S, Nofech-Mozes S, Badve SS, Hanna W, Hughes LL, Wood WC, Davidson NE, Paszat L, Shak S, Sparano JA, Solin LJ.

Breast Cancer Res Treat. 2018 Jun;169(2):359-369. doi: 10.1007/s10549-018-4693-2. Epub 2018 Jan 31.

7.

Interaction of Postmastectomy Radiation Treatment With Breast Reconstruction: Many Questions, Emerging Data.

Solin LJ.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx177. No abstract available.

PMID:
28954301
8.

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ, Hortobagyi GN.

CA Cancer J Clin. 2017 Jul 8;67(4):290-303. doi: 10.3322/caac.21393. Epub 2017 Mar 14. Erratum in: CA Cancer J Clin. 2017 Jul 8;67(4):345.

9.

Reply to L.B. Marks et al.

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Sledge GW Jr, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB.

J Clin Oncol. 2017 Apr 10;35(11):1258-1259. doi: 10.1200/JCO.2016.71.3966. Epub 2017 Jan 9. No abstract available.

PMID:
28068171
10.

No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.

Vapiwala N, Hwang WT, Kushner CJ, Schnall MD, Freedman GM, Solin LJ.

Cancer. 2017 Apr 15;123(8):1324-1332. doi: 10.1002/cncr.30479. Epub 2016 Dec 16.

11.

Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.

Manders JB, Kuerer HM, Smith BD, McCluskey C, Farrar WB, Frazier TG, Li L, Leonard CE, Carter DL, Chawla S, Medeiros LE, Guenther JM, Castellini LE, Buchholz DJ, Mamounas EP, Wapnir IL, Horst KC, Chagpar A, Evans SB, Riker AI, Vali FS, Solin LJ, Jablon L, Recht A, Sharma R, Lu R, Sing AP, Hwang ES, White J; Study investigators and study participants.

Ann Surg Oncol. 2017 Mar;24(3):660-668. doi: 10.1245/s10434-016-5583-7. Epub 2016 Oct 4.

12.

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Sledge GW Jr, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):e219-e234. doi: 10.1016/j.prro.2016.08.009. Epub 2016 Sep 19. Review.

PMID:
27659727
13.

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Sledge GW Jr, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB.

J Clin Oncol. 2016 Dec 20;34(36):4431-4442. doi: 10.1200/JCO.2016.69.1188. Epub 2016 Sep 30. Review.

PMID:
27646947
14.

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Sledge GW Jr, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge SB.

Ann Surg Oncol. 2017 Jan;24(1):38-51. doi: 10.1245/s10434-016-5558-8. Epub 2016 Sep 19.

15.

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS.

Pract Radiat Oncol. 2016 Sep-Oct;6(5):287-295. doi: 10.1016/j.prro.2016.06.011. Epub 2016 Jun 24.

16.

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS.

J Clin Oncol. 2016 Nov 20;34(33):4040-4046. doi: 10.1200/JCO.2016.68.3573. Epub 2016 Oct 31.

17.

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Marinovich ML, Azizi L, Macaskill P, Irwig L, Morrow M, Solin LJ, Houssami N.

Ann Surg Oncol. 2016 Nov;23(12):3811-3821. Epub 2016 Aug 15. Review.

18.

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.

Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS.

Ann Surg Oncol. 2016 Nov;23(12):3801-3810. Epub 2016 Aug 15. Review.

19.

Reply to C. Shah et al.

Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE.

J Clin Oncol. 2016 May 20;34(15):1824-5. doi: 10.1200/JCO.2016.66.4714. Epub 2016 Mar 21. No abstract available.

PMID:
27001578
20.

Treatment and Long-term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.

Recht A, Rakovitch E, Solin LJ.

JAMA Oncol. 2016 Mar;2(3):396. doi: 10.1001/jamaoncol.2015.4854. No abstract available.

PMID:
26967178
21.

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.

Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE.

J Clin Oncol. 2015 Nov 20;33(33):3938-44. doi: 10.1200/JCO.2015.60.8588. Epub 2015 Sep 14.

22.

Controversies in Radiation Oncology for Early-Stage Breast Cancer.

Bellon JR, Golshan M, Solin LJ.

Ann Surg Oncol. 2015 Oct;22(10):3213-8. doi: 10.1245/s10434-015-4713-y. Epub 2015 Jul 23.

PMID:
26202560
23.

The current clinical value of the DCIS Score.

Wood WC, Alvarado M, Buchholz DJ, Hyams D, Hwang S, Manders J, Park C, Solin LJ, White J, Willey S.

Oncology (Williston Park). 2014 May;28 Suppl 2:C2, 1-8, C3.

24.

Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.

Tevaarwerk AJ, Wang M, Zhao F, Fetting JH, Cella D, Wagner LI, Martino S, Ingle JN, Sparano JA, Solin LJ, Wood WC, Robert NJ.

J Clin Oncol. 2014 Dec 10;32(35):3948-58. doi: 10.1200/JCO.2014.55.6993. Epub 2014 Oct 27.

25.

Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of breast cancer management.

Solin LJ, Truong PT, Russo J, Tsuda H, Santa-Maria CA, Wolf AC.

Breast Cancer Manag. 2014 May;3(3):227-228. No abstract available.

26.

An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence.

Houssami N, Turner R, Macaskill P, Turnbull LW, McCready DR, Tuttle TM, Vapiwala N, Solin LJ.

J Clin Oncol. 2014 Feb 10;32(5):392-401. doi: 10.1200/JCO.2013.52.7515. Epub 2014 Jan 6.

PMID:
24395846
27.

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.

Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, Cherbavaz DB, Shak S, Page DL, Sledge GW Jr, Davidson NE, Ingle JN, Perez EA, Wood WC, Sparano JA, Badve S.

J Natl Cancer Inst. 2013 May 15;105(10):701-10. doi: 10.1093/jnci/djt067. Epub 2013 May 2.

28.

Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.

Berman AT, Thukral AD, Hwang WT, Solin LJ, Vapiwala N.

Clin Breast Cancer. 2013 Apr;13(2):88-94. doi: 10.1016/j.clbc.2012.11.001. Epub 2012 Dec 5.

PMID:
23218473
29.

Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.

Schwartz GF, Bartelink H, Burstein HJ, Cady B, Cataliotti L, Fentiman IS, Holland R, Hughes KS, Masood S, McCormick B, Palazzo JA, Pressman PI, Reis-Filho J, Pusztai L, Rutgers EJ, Seidman AD, Solin LJ, Sparano JA.

Breast J. 2012 Jul-Aug;18(4):303-11. doi: 10.1111/j.1524-4741.2012.01264.x.

PMID:
22759093
30.

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.

Solin LJ, Gray R, Goldstein LJ, Recht A, Baehner FL, Shak S, Badve S, Perez EA, Shulman LN, Martino S, Davidson NE, Sledge GW Jr, Sparano JA.

Breast Cancer Res Treat. 2012 Jul;134(2):683-92. doi: 10.1007/s10549-012-2072-y. Epub 2012 May 1.

31.

Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer.

Bar Ad V, Dutta PR, Solin LJ, Hwang WT, Tan KS, Both S, Cheville A, Harris EE.

Breast J. 2012 May-Jun;18(3):219-25. doi: 10.1111/j.1524-4741.2012.01229.x. Epub 2012 Apr 5.

PMID:
22487094
32.

Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.

Schwartz GF, Reis-Fihlo J, Pusztai L, Fentiman IS, Holland R, Bartelink H, Rutgers EJ, Solin LJ, Palazzo J; Consensus Committee.

Cancer. 2012 Apr 15;118(8):2031-8. doi: 10.1002/cncr.27431. Epub 2012 Mar 5.

33.

Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues.

Solin LJ.

J Clin Oncol. 2012 Feb 20;30(6):577-9. doi: 10.1200/JCO.2011.39.6929. Epub 2012 Jan 17. No abstract available.

PMID:
22253465
34.

The impact of re-excision and residual disease on local recurrence after breast conservation treatment for patients with early stage breast cancer.

Ali AN, Vapiwala N, Guo M, Hwang WT, Harris EE, Solin LJ.

Clin Breast Cancer. 2011 Dec;11(6):400-5. doi: 10.1016/j.clbc.2011.08.003. Epub 2011 Oct 10.

PMID:
21993010
35.
36.

Breast-conserving surgery and radiotherapy in early-stage breast cancer: the importance of local control.

Recht A, Solin LJ.

Semin Radiat Oncol. 2011 Jan;21(1):3-9. doi: 10.1016/j.semradonc.2010.08.001. Review.

PMID:
21134648
37.

Risk factors for lymphedema after breast cancer treatment.

Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46. doi: 10.1158/1055-9965.EPI-09-1245. Epub 2010 Oct 26.

38.

The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast.

Solin LJ.

J Natl Cancer Inst Monogr. 2010;2010(41):187-92. doi: 10.1093/jncimonographs/lgq020. Review.

39.

Use of lymphoscintigraphy in radiation treatment of primary breast cancer in the context of lymphedema risk reduction.

Das IJ, Cheville AL, Scheuermann J, Srinivas SM, Alavi A, Solin LJ.

Radiother Oncol. 2011 Aug;100(2):293-8. doi: 10.1016/j.radonc.2010.09.016. Epub 2010 Oct 14.

PMID:
20951451
40.

Tailored local-regional treatment for early-stage breast cancer.

Solin LJ.

Clin Breast Cancer. 2010 Oct 1;10(5):343-4. doi: 10.3816/CBC.2010.n.044. No abstract available.

PMID:
20920977
41.

Controversies in breast surgery.

Boughey JC, Mittendorf EA, Solin LJ, Michael Dixon J, Tuttle TM, Beitsch PD, Cody HS, Leitch AM, Newman LA.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:230-2. doi: 10.1245/s10434-010-1264-0. Epub 2010 Sep 19. No abstract available.

PMID:
20853038
42.

An appraisal of pre-operative MRI in breast cancer: more effective staging of the breast or much ado about nothing?

Houssami N, Solin LJ.

Maturitas. 2010 Dec;67(4):291-3. doi: 10.1016/j.maturitas.2010.08.008. Epub 2010 Sep 21. No abstract available.

PMID:
20863636
43.

Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy.

Houssami N, Macaskill P, Marinovich ML, Dixon JM, Irwig L, Brennan ME, Solin LJ.

Eur J Cancer. 2010 Dec;46(18):3219-32. doi: 10.1016/j.ejca.2010.07.043. Review.

PMID:
20817513
44.

Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost.

Hill-Kayser CE, Chacko D, Hwang WT, Vapiwala N, Solin LJ.

Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1048-54. doi: 10.1016/j.ijrobp.2009.12.026. Epub 2010 May 24.

PMID:
20510548
45.

Advances in local-regional treatment for patients with early-stage breast cancer: a review of the field.

Reintgen C, Reintgen D, Solin LJ.

Clin Breast Cancer. 2010 Jun;10(3):180-7. doi: 10.3816/CBC.2010.n.025. Review.

PMID:
20497916
46.

Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy.

Yee SS, Dutta PR, Solin LJ, Vapiwala N, Kao GD.

J Support Oncol. 2010 Jan-Feb;8(1):28-34.

PMID:
20235421
47.

Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.

Dorsey JF, Dowling ML, Kim M, Voong R, Solin LJ, Kao GD.

Cancer Biol Ther. 2010 May 15;9(10):809-18.

48.
49.

Role of anemia prior to radiation treatment in local recurrence and survival after breast conservation treatment for early-stage breast cancer.

Harris EE, Kasi S, Hwang WT, Vapiwala N, Solin LJ.

Clin Breast Cancer. 2010 Feb;10(1):74-80. doi: 10.3816/CBC.2010.n.010.

PMID:
20133262
50.

Defining the clinical utility of gene expression assays in breast cancer: the intersection of science and art in clinical decision making.

Sparano JA, Solin LJ.

J Clin Oncol. 2010 Apr 1;28(10):1625-7. doi: 10.1200/JCO.2009.25.2882. Epub 2010 Jan 11. No abstract available.

PMID:
20065178

Supplemental Content

Loading ...
Support Center